Verition Fund Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Verition Fund Management's HALO Position: Q2 2026 in Review
Verition Fund Management opened a new position in Halozyme (HALO) in Q2 2026: 12,500 shares worth $978K. The stake represents 0.01% of the portfolio and ranks #1423 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in HALO as recently as Q4 2025.
Verition Fund Management first reported a position in HALO in Q2 2014 and has held it in 26 quarters since. The position peaked at $5M in Q3 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Verition Fund Management held 12,500 shares of Halozyme worth $978K as of Q2 2026.
- Halozyme was a new Verition Fund Management position in Q2 2026.
- Halozyme made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1423 holding.
- Verition Fund Management first reported a position in Halozyme in Q2 2014 and has held it in 26 quarters since.
- Verition Fund Management's Halozyme position peaked at $5M in Q3 2025.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.